CN104107212A - Medicine for treating hepatitis disease and production method thereof - Google Patents
Medicine for treating hepatitis disease and production method thereof Download PDFInfo
- Publication number
- CN104107212A CN104107212A CN201410377706.XA CN201410377706A CN104107212A CN 104107212 A CN104107212 A CN 104107212A CN 201410377706 A CN201410377706 A CN 201410377706A CN 104107212 A CN104107212 A CN 104107212A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- medicine
- hepatitis
- production method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating a hepatitis disease and a production method thereof. The medicine for treating the hepatitis disease is characterized by being prepared from the following raw materials: 2-3g of antelope horn, 0.025-0.035g of calculus bovis, 0.025-0.035g of musk, 4-5g of dandelion, 0.12-0.14g of muskmelon pedicel, 5-15g of artemisia stelleriana and 4-6g of liquorice. The medicine for treating the hepatitis disease has the advantages of careful and scientific selection of materials and good curative effect on the hepatitis disease caused by excessive impatience and excessive fatigue; the production method of the medicine for treating the hepatitis disease is simple, and raw materials can be conveniently purchased; therefore, the medicine for treating the hepatitis disease and the production method thereof are very good.
Description
Technical field:
The present invention relates to a kind of medicine and production method thereof, particularly a kind of medicine and production method thereof for the treatment of hepatitis.
Background technology:
Although there is the medicine of various treatment hepatitis at present, but poor effect mostly, the side effect of western medicine hepatitis is large, also there is no a kind of Chinese patent medicine of good treatment hepatitis, and the medicine of existing treatment hepatitis, cost is high, and the raw material source of goods is few, can not meet the needs of the growing life of people.
Summary of the invention:
The object of the invention is to invent a kind of medicine and production method thereof for the treatment of hepatitis, medicine ample supply and prompt delivery and the cost of this treatment hepatitis are lower, can meet increasing hepatitis human needs, in order to overcome the deficiency of existing treatment hepatitis medicine.
Object of the present invention can reach by following embodiment: the consumption of the each raw material of this treatment hepatitis medicine is: 2～3 grams of Cornu Saigae Tataricae, 0.025～0.035 gram of Calculus Bovis, 0.025～0.035 gram, Moschus, 4～5 grams of Herba Taraxacis, 0.12～0.14 gram of muskmelon pedicel, 5～15 grams of Herba Artemisiae Sieversianaes, 4～6 grams, Radix Glycyrrhizae.Production method of the present invention, for each medical material is cleaned respectively, is dried under 70 degree conditions Celsius, pulverize, cross 200 mesh sieves, each medicated powder is combined, stir, with every 0.45 gram of capsule shells fill patent medicine.
Advantage of the present invention is ample supply and prompt delivery, carefully selected materials, science, can treat worry excessively, overwork due to hepatitis patient.This method for producing medicines is simple, and raw material is purchased conveniently, is a kind of medicine and production method thereof of good treatment hepatitis.
Detailed description of the invention:
3 embodiment of raw material consumption of the present invention below:
1, the each raw material consumption of the medicine of this treatment hepatitis is: 2 grams of Cornu Saigae Tataricae, 0.025 gram of Calculus Bovis, 0.025 gram, Moschus, 4 grams of Herba Taraxacis, 0.12 gram of muskmelon pedicel, 5 grams of Herba Artemisiae Sieversianaes, 4 grams, Radix Glycyrrhizae.
2, the each raw material consumption of the medicine of this treatment hepatitis is: 2.5 grams of Cornu Saigae Tataricae, 0.03 gram of Calculus Bovis, 0.03 gram, Moschus, 4.5 grams of Herba Taraxacis, 0.13 gram of muskmelon pedicel, 10 grams of Herba Artemisiae Sieversianaes, 5 grams, Radix Glycyrrhizae.
3, the each raw material consumption of the medicine of this treatment hepatitis is: 6 grams of 3 grams of Cornu Saigae Tataricae, 0.035 gram of Calculus Bovis, 0.035 gram, Moschus, 5 grams of Herba Taraxacis, 0.14 gram of muskmelon pedicel, Herba Artemisiae Sieversianae 15, Radix Glycyrrhizae.
The all raw materials of the present invention are commercially available.
The production method of the embodiment of the present invention, for each medical material is cleaned respectively, is dried under 70 degree conditions Celsius, pulverize, cross 200 mesh sieves, each medicated powder is combined, stir, with every 0.45 gram of capsule shells fill patent medicine.
The present invention's pharmacy as a large amount of in need can increase material quantity by above-mentioned weight ratio.
Usage of the present invention is for taking after meal 3～6 half an hour, and day takes 2 times, and boiled water send down, and 10 days 1 courses for the treatment of, take effect 2 courses for the treatment of.
The present invention, by probation, treats 150 examples, recovery from illness 145 examples, 5 examples that take effect, invalid 0 example.
Pharmacology analysis of the present invention: Cornu Saigae Tataricae heat clearing away power is strong, is apt to into liver, has good removing heat from the liver, the effect of breath liver-wind; Calculus Bovis has that function of gallbladder promoting protects the liver, antiinflammatory, analgesic activity; Muskmelon pedicel removes polyp in abdomen, treats jaundice; Moschus is had one's ideas straightened out, reducing swelling and alleviating pain, promoting blood circulation to remove obstruction in the collateral, control swollen ulcer drug; In Herba Taraxaci plant, contain the multiple health-nutrition compositions such as taraxol, taraxacin, choline, organic acid, inulin, have the effects such as diuresis, cathartic, jaundice eliminating subcutaneous ulcer, function of gallbladder promoting; Herba Taraxaci contains protein, fat, carbohydrate, trace element and vitamin etc. simultaneously, has abundant nutritive value; The swollen heat cough of Herba Artemisiae Sieversianae treatment, swelling and sore throat, jaundice due to damp-heat, hematodiarrhoea gonorrhea, rheumatic arthralgia, scabies defect malignant boil; Prevent and treat hepatitis; Radix Glycyrrhizae can relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.Overall compatibility is in a word a kind of good medicine for the treatment of hepatitis.
Zhao, man, 40 years old, because I do not note life style, be busy with all day long work, temper is fast, likes to worry, and causes the tired food of body to decline, and obtains hepatitis, has also brought inconvenience to work.Take 2 20 days courses for the treatment of of this medicine, obviously to get better.
Chen, female, 45 years old, in foreign enterprise's work, due to too diligently, excessive thinking, causes nutrient blood consumption wound, interior raw deficiency-heat, lies awake all night, obtained hepatitis.By this Drug therapy 20 days, symptom completely without.
Beam, man, 50 years old, in the work of individual enterprise, for the salaries of taking, work did not have rule more, longevity of service is overworked, in the course of time, must hepatitis.Take this medicine 20 days, with regard to physical rehabilitation.
Huang, female, 35 years old, due in the work of zinc-plated factory, work under bad environment, labor intensity is large, and my temper is anxious, overworks, and unconsciously obtains hepatitis, by this Drug therapy 30 days, just feels much better.
Lee, man, 50 years old, in research unit's work, temper was anxious, and work is risked one's life, and often stays up late, and heart failure, has suffered from hepatitis.By this Drug therapy 20 days, be just clearly better.
Zhang, female, 60 years old, nineteen fifty-three was raw.Like to quarrel to husband, worry every day and get angry, the careless hepatitis that obtained, takes this medicine 30 days, and hepatopathy symptom has just been eliminated.
Claims (5)
1. treat a medicine for hepatitis, it is characterized in that the consumption of each raw material is: 2～3 grams of Cornu Saigae Tataricae, 0.025～0.035 gram of Calculus Bovis, 0.025～0.035 gram, Moschus, 4～5 grams of Herba Taraxacis, 0.12～0.14 gram of muskmelon pedicel, 5～15 grams of Herba Artemisiae Sieversianaes, 4～6 grams, Radix Glycyrrhizae; Each medical material is cleaned respectively, under 70 degree conditions Celsius, dries, pulverize, cross 200 mesh sieves, each medicated powder is combined, stir, with every 0.45 gram of capsule shells fill patent medicine.
2. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the consumption of each raw material is: 2 grams of Cornu Saigae Tataricae, 0.025 gram of Calculus Bovis, 0.025 gram, Moschus, 4 grams of Herba Taraxacis, 0.12 gram of muskmelon pedicel, 5 grams of Herba Artemisiae Sieversianaes, 4 grams, Radix Glycyrrhizae.
3. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the consumption of each raw material is: 2.5 grams of Cornu Saigae Tataricae, 0.03 gram of Calculus Bovis, 0.03 gram, Moschus, 4.5 grams of Herba Taraxacis, 0.13 gram of muskmelon pedicel, 10 grams of Herba Artemisiae Sieversianaes, 5 grams, Radix Glycyrrhizae.
4. the medicine for the treatment of hepatitis according to claim 1, is characterized in that the consumption of each raw material is: 3 grams of Cornu Saigae Tataricae, 0.035 gram of Calculus Bovis, 0.035 gram, Moschus, 5 grams of Herba Taraxacis, 0.14 gram of muskmelon pedicel, 15 grams of Herba Artemisiae Sieversianaes, 6 grams, Radix Glycyrrhizae.
5. the production method of the medicine of the treatment hepatitis as described in claim 1～4 any one claim, it is characterized in that its production method is that each medical material is cleaned respectively, under 70 degree conditions Celsius, dry, pulverize, cross 200 mesh sieves, each medicated powder is combined, stirs, with every 0.45 gram of capsule shells fill patent medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410377706.XA CN104107212A (en) | 2014-08-01 | 2014-08-01 | Medicine for treating hepatitis disease and production method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410377706.XA CN104107212A (en) | 2014-08-01 | 2014-08-01 | Medicine for treating hepatitis disease and production method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104107212A true CN104107212A (en) | 2014-10-22 |
Family
ID=51704332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410377706.XA Pending CN104107212A (en) | 2014-08-01 | 2014-08-01 | Medicine for treating hepatitis disease and production method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104107212A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107243018A (en) * | 2017-07-12 | 2017-10-13 | 刘清生 | Treat hepatitis, hepatitis B, hepatitis external application Chinese medicine and smoke medicine, method of preparation and use |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101190317A (en) * | 2006-11-20 | 2008-06-04 | 马年 | Compound carapax trionycis capsule for expelling toxin, softening liver and becoming yin |
| CN101972297A (en) * | 2010-03-30 | 2011-02-16 | 张铁辉 | Liver health tablet |
| CN102692477A (en) * | 2012-06-14 | 2012-09-26 | 漳州片仔癀药业股份有限公司 | Medicinal composition used for treating fatty liver and quality detection method thereof |
-
2014
- 2014-08-01 CN CN201410377706.XA patent/CN104107212A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101190317A (en) * | 2006-11-20 | 2008-06-04 | 马年 | Compound carapax trionycis capsule for expelling toxin, softening liver and becoming yin |
| CN101972297A (en) * | 2010-03-30 | 2011-02-16 | 张铁辉 | Liver health tablet |
| CN102692477A (en) * | 2012-06-14 | 2012-09-26 | 漳州片仔癀药业股份有限公司 | Medicinal composition used for treating fatty liver and quality detection method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107243018A (en) * | 2017-07-12 | 2017-10-13 | 刘清生 | Treat hepatitis, hepatitis B, hepatitis external application Chinese medicine and smoke medicine, method of preparation and use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103211899B (en) | Method for treating psoriasis | |
| CN110354236A (en) | A kind of pharmaceutical composition and preparation method thereof for treating sympotoms caused by cold factors | |
| CN104107212A (en) | Medicine for treating hepatitis disease and production method thereof | |
| CN102631581B (en) | Medicament for treating agrypnia and production method thereof | |
| CN101439149B (en) | Chinese medicinal composition for treating gastric ulcer, gastrorrhagia and gastric perforation | |
| CN104107414A (en) | Medicine for treating esophagus cancer disease and production method thereof | |
| CN105663370A (en) | Externally-used medicine for treating verruca plantaris | |
| CN104127695A (en) | Liver cancer treatment drug and production method thereof | |
| CN105213685B (en) | A kind of traditional Chinese medicinal ointment for treating burn, diabetes | |
| CN107929644A (en) | A kind of Chinese medicine composition for treating sinus bradycardia and preparation method thereof | |
| CN103948682B (en) | One treats the ARR Chinese medicine of type of insufficiency of heart-blood | |
| CN103550723B (en) | Traditional Chinese medicine preparation for treating Raynaud disease | |
| CN102961540A (en) | Medicine for treating coronary heart disease and preparation method for same | |
| CN102614469B (en) | Production method of medicine for treating heat obstruction | |
| CN101797330B (en) | Lipid regulating and meridians activating capsule | |
| CN101972355A (en) | Traditional Chinese medicine for tonifying kidney comprehensively | |
| CN102008697A (en) | Medicinal liquor for curing nephropathy and preparation method thereof | |
| CN103656501B (en) | The medicine pill for the treatment of spontaneous angina pectoris | |
| CN105327288A (en) | Drug for treating breast hyperplasia | |
| CN105012913A (en) | Drug for treating cold cough and preparation method of drug | |
| CN103948804B (en) | A kind of Chinese medicine composition treating lung qi deficiency dermatitis aestivale | |
| CN104096210A (en) | Medicine for treating chest distress and pain and gastritis and production method of medicine | |
| CN104107287A (en) | Medicament for treating ascites due to cirrhosis and cardiorenal ascites syndrome and production method of medicament | |
| CN104587432A (en) | Traditional Chinese medicine composition for treating essential hypotension | |
| CN104306811B (en) | A kind of Chinese medicine composition for treating children's psoriasis vulgaris |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141022 |
|
| RJ01 | Rejection of invention patent application after publication |